Summary:
Testosterone Replacement therapy for assessment of long-term Vascular Events and efficacy response in hypogonadal men
Qualified Participants Must:
• Men 45 to 85
•
Have low testosterone
•
Evidence of pre-existing cardiovascular (CV) disease
•
Sign or symptom of low-T such as decreased sexual desire, decreased energy or fatigue, low mood or depressed mood, loss of body hair
•
Not on or had history of taking growth hormones, anti-estrogen or estrogen treatment
• no history of cancer
Qualified Participants May Receive:
Enrolled patients will potentially receive testosterone replacement therapy or placebo, study related medical care, and compensation for their time and travel.